Investigational treatment for wheat and gluten allergies
Part of Immune system & allergy clinical trials.
This study tests an investigational medication (LP-003) to see if it can reduce allergic reactions to wheat or gluten. It might help people who currently experience symptoms like hives or stomach problems when they eat these foods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 12 and 60 years old
- Have a history of allergy to wheat or gluten
- Have a positive allergy test (skin prick or blood test) to wheat or gluten
- Have allergy symptoms triggered by eating less than 24 grams of gluten protein during a food challenge
- Agree to use effective birth control during the trial
- Understand and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called LP-005 for people with kidney disease caused by an overactive part of the immune system called the complement system. It aims to see if the drug is safe and effective for reducing kidney damage.
This study tests a new medication called LP-003 that may help people with peanut allergy tolerate peanuts better. If you qualify, you might receive the drug or a placebo, and researchers will see if it reduces allergic reactions to peanuts.
This trial tests an injection called LP-003 for people with allergic asthma that is not well controlled by current inhalers and other medications. It aims to see if the drug can improve asthma control and reduce flare-ups.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This trial studies whether a dietary approach can help people with mild-to-moderate psoriasis. It may be especially focused on people who do not have signs of wheat/gluten-related immune reactions.
Hear when a new Food Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.